ERBB2 and triple-negative breast carcinoma: Among all the breast cancer cases, 15% are triple-negative breast cancers (TNBCs), which lack expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) and have a very aggressive disease course [3].